Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2693431000168110 | Fluticasone plus Salmeterol 125/25 (Cipla) (fluticasone propionate 125 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation) inhalation, actuation (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2693441000168118 | Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | has manufactured dose form | inhalation | true | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | Is a | fluticasone propionate 125 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation inhalation, actuation (medicinal product unit of use) | true | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | Is a | Fluticasone plus Salmeterol 125/25 (Cipla) | true | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | has manufactured dose form | pressurised inhalation | false | Inferred relationship | Some | ||
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | has unit of use | actuation | true | Inferred relationship | Some | 2048147863 | |
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | has intended active ingredient | salmeterol | true | Inferred relationship | Some | 1539194678 | |
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | has Australian BoSS | salmeterol | true | Inferred relationship | Some | 1539194678 | |
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | has intended active ingredient | fluticasone propionate | true | Inferred relationship | Some | 2048147862 | |
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | has Australian BoSS | fluticasone propionate | true | Inferred relationship | Some | 2048147862 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, 120 actuations, aerosol can | has TPUU | True | Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | Inferred relationship | Some | 1 |
| Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, 120 actuations | has TPUU | True | Fluticasone plus Salmeterol 125/25 (Cipla) inhalation, actuation | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR